Hybribio Biotech updates on subsidiary loan guarantee, collateral swap

Guangdong Hybribio Biotech announced an update on its wholly-owned subsidiary, Hybribio Medical Industry Co. Ltd., regarding a syndicated loan. The company will swap collateral for the loan, replacing land use rights at the Hybribio Medical Science Park project with its own property in the High-Tech Zone. This change is necessary to process a land nature alteration for the original collateral. The replacement collateral is valued at CNY 57,441,600.

Following this, Hybribio Biotech’s total guarantee for its subsidiaries will be CNY 52,740,000, representing 1.28% of the latest audited net assets attributable to the parent company. The board authorized the chairman to approve the financing and sign related legal documents. The company stated the collateral swap will not adversely affect its operations or shareholder interests.

Separately, the company will use raised funds to replace CNY 9,390,908.85 of self-funded personnel expenses incurred over the past six months for its investment projects. This is to align with bank requirements for salary accounts, improve capital utilization, and ensure compliance with remuneration distribution. This action is within the board’s approval authority and does not alter the intended use of the raised capital.